These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36197132)
1. The economic and societal burden of Alzheimer disease: managed care considerations. Skaria AP Am J Manag Care; 2022 Sep; 28(10 Suppl):S188-S196. PubMed ID: 36197132 [TBL] [Abstract][Full Text] [Related]
2. Economic burden of Alzheimer disease and managed care considerations. Wong W Am J Manag Care; 2020 Aug; 26(8 Suppl):S177-S183. PubMed ID: 32840331 [TBL] [Abstract][Full Text] [Related]
10. The societal economic burden of autosomal dominant polycystic kidney disease in the United States. Cloutier M; Manceur AM; Guerin A; Aigbogun MS; Oberdhan D; Gauthier-Loiselle M BMC Health Serv Res; 2020 Feb; 20(1):126. PubMed ID: 32070341 [TBL] [Abstract][Full Text] [Related]
13. The effectiveness of school-based family asthma educational programs on the quality of life and number of asthma exacerbations of children aged five to 18 years diagnosed with asthma: a systematic review protocol. Walter H; Sadeque-Iqbal F; Ulysse R; Castillo D; Fitzpatrick A; Singleton J JBI Database System Rev Implement Rep; 2015 Oct; 13(10):69-81. PubMed ID: 26571284 [TBL] [Abstract][Full Text] [Related]
14. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective. Rice DP; Fillit HM; Max W; Knopman DS; Lloyd JR; Duttagupta S Am J Manag Care; 2001 Aug; 7(8):809-18. PubMed ID: 11519239 [TBL] [Abstract][Full Text] [Related]
16. The cost of Alzheimer's disease in managed care: a cross-sectional study. Leon J; Neumann PJ Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408 [TBL] [Abstract][Full Text] [Related]
17. Costs and resource use of community-dwelling patients with Alzheimer's disease in Japan: 18-month results from the GERAS-J study. Nakanishi M; Igarashi A; Ueda K; Brnabic AJM; Matsumura T; Meguro K; Yamada M; Mimura M; Arai H; Treuer T Curr Med Res Opin; 2021 Aug; 37(8):1331-1339. PubMed ID: 33904362 [TBL] [Abstract][Full Text] [Related]
18. Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study. Lenox-Smith A; Reed C; Lebrec J; Belger M; Jones RW BMC Geriatr; 2016 Nov; 16(1):195. PubMed ID: 27887645 [TBL] [Abstract][Full Text] [Related]
19. Economic Burden of Alzheimer's Disease Dementia in Japan. Ikeda S; Mimura M; Ikeda M; Wada-Isoe K; Azuma M; Inoue S; Tomita K J Alzheimers Dis; 2021; 81(1):309-319. PubMed ID: 33780371 [TBL] [Abstract][Full Text] [Related]